🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada

Recruitingn/aAges 18 Years - anyAllMcGill University
NCT07095192 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The SCALE-POCT study is a national initiative designed to provide robust evidence for scaling up point-of-care hepatitis C testing for key populations. The study seeks to map current hepatitis C clinical processes, identify barriers and facilitators to implementation, and co-design practical tools and strategies in partnership with stakeholders. A major obstacle to hepatitis C elimination and increasing treatment uptake is the current multi-step diagnostic process, which leads to loss to follow-up and treatment delays, particularly among high-risk groups such as people who inject drugs. Point of-care hepatitis C antibody tests (results: 5-20 mins) and RNA tests (results: 60 mins), could enable single-visit diagnosis, reducing loss to follow-up. However, integrating these tests into key settings presents challenges. The overarching goal of this study is to generate evidence to inform the

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Individuals aged ≥18 years who have a risk factor for HCV acquisition or are attending a site that provides services to people with an HCV acquisition risk. * Service providers and managers who are currently employed at a site providing HCV-related services, involved in or supervising the delivery of HCV-related services. * Policymaker must hold a position in local, provincial, or national government or a health authority that influences HCV testing/treatment policies and be able to provide insights into the strategic planning and funding for HCV care. * Laboratory and quality assurance stakeholders must hold a role in laboratory services, quality assurance, or regulatory oversight of point-of-care testing at the provincial, national, or organizational level. Exclusion Criteria: * Younger than 18 years old
💊

What it tests

  • Preimplementation of HCV Point of care testing
📍

Where

12 sites
Anonyme L'Unite D'Intervention
Montreal, Canada
McGill University
Montreal, Canada
Indigenous Health Centre of Tiohtià:ke
Montreal, Canada
L'Anonyme
Montreal, Canada
Centre de réadaptation en dépendance de Québec (CRDQ)
Québec, Canada
Medicins du Monde
Montreal, Canada
Okanagan prison
Okanagan, Canada
SABSA Cooperative
Québec, Canada

…and 4 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy